IMCR (STOCKS)
Immunocore Holdings plc American Depositary Shares
$32.930000
+0.110000 (+0.34%)
Prev close: $32.820000
Company Information
- Exchange
- XNAS
- Sector
- Health Technology
- Industry
- Biotechnology
- CEO
- Bahija Jallal
- Asset Type
- stocks
- Website
- Visit
Fundamentals
- Market Cap
- $1,708.15M
- Employees
- 493
- P/E (TTM)
- -56.37
- P/B (TTM)
- 4.20
- Dividend Yield
- —
Technical Indicators
- SMA 10
- —
- SMA 20
- —
- SMA 50
- —
- EMA 9
- —
- EMA 21
- —
- RSI
- —
- MACD State
- —
Recent News
No recent news found for this ticker.
Financial Statements
| Revenues | $379.59M |
| Benefits Costs and Expenses | $407.72M |
| Cost Of Revenue | $2.71M |
| Costs And Expenses | $407.72M |
| Gross Profit | $376.88M |
| Operating Expenses | $421.99M |
| Selling, General, and Administrative Expenses | $165.09M |
| Research and Development | $256.90M |
| Operating Income/Loss | -$45.11M |
| Income/Loss From Continuing Operations After Tax | -$29.23M |
| Income/Loss From Continuing Operations Before Tax | -$28.13M |
| Income Tax Expense/Benefit | $1.10M |
| Net Income/Loss | -$29.23M |
| Net Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Net Income/Loss Attributable To Parent | -$29.23M |
| Net Income/Loss Available To Common Stockholders, Basic | -$29.23M |
| Participating Securities, Distributed And Undistributed Earnings/Loss, Basic | $0.00 |
| Preferred Stock Dividends And Other Adjustments | $0.00 |
| Basic Earnings Per Share | -$0.58 |
| Diluted Earnings Per Share | -$0.58 |
| Basic Average Shares | 100,614,532 |
| Diluted Average Shares | 100,614,532 |
| Assets | $1.10B |
| Current Assets | $1.02B |
| Inventory | $5.66M |
| Other Current Assets | $1.02B |
| Noncurrent Assets | $79.65M |
| Fixed Assets | $9.43M |
| Other Non-current Assets | $70.22M |
| Liabilities | $705.94M |
| Current Liabilities | $170.35M |
| Accounts Payable | $22.96M |
| Wages | $10.79M |
| Other Current Liabilities | $136.61M |
| Noncurrent Liabilities | $535.58M |
| Equity | $396.56M |
| Equity Attributable To Noncontrolling Interest | $0.00 |
| Equity Attributable To Parent | $396.56M |
| Liabilities And Equity | $1.10B |
| Net Cash Flow From Operating Activities | $7.99M |
| Net Cash Flow From Operating Activities, Continuing | $7.99M |
| Net Cash Flow From Investing Activities | -$19.00M |
| Net Cash Flow From Investing Activities, Continuing | -$19.00M |
| Net Cash Flow From Financing Activities | -$43.42M |
| Net Cash Flow From Financing Activities, Continuing | -$43.42M |
| Exchange Gains/Losses | $15.08M |
| Net Cash Flow | -$39.35M |
| Net Cash Flow, Continuing | -$54.43M |
| Comprehensive Income/Loss | -$28.06M |
| Comprehensive Income/Loss Attributable To Noncontrolling Interest | $0.00 |
| Comprehensive Income/Loss Attributable To Parent | -$28.06M |
| Other Comprehensive Income/Loss | $28.48M |